| Authors: |
Greaney AM; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06511, USA., Ramachandra AB; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA., Yuan Y; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06511, USA.; Department of Anesthesiology, Yale School of Medicine, New Haven, CT 06510, USA., Korneva A; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA., Humphrey JD; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06511, USA., Niklason LE; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06511, USA.; Department of Anesthesiology, Yale School of Medicine, New Haven, CT 06510, USA.; Humacyte Inc., Durham, NC 27713, USA. |
